World's Best Scientists 2026 revealed!
Suzanne M. Garland

Suzanne M. Garland

Award Badge
Microbiology
Australia
2026

D-Index & Metrics

Microbiology

D-Index
102
Citations
49021
World Ranking
362
National Ranking
8

Medicine

D-Index
102
Citations
51203
World Ranking
7534
National Ranking
224

Suzanne M. Garland publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Suzanne M. Garland sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 682 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Suzanne M. Garland D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Suzanne M. Garland sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 102 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in Australia Leader Award
  • 2025 - Research.com Microbiology in Australia Leader Award
  • 2023 - Research.com Microbiology in Australia Leader Award
  • 2022 - Research.com Microbiology in Australia Leader Award

Overview

Suzanne M. Garland is affiliated with the University of Melbourne in Australia. Their research work primarily spans the field of Medicine, with a strong focus on Epidemiology, Microbiology, Surgery, Oncology, and Hematology as key subfields.

Their main topics of study include Cervical Cancer and HPV Research, Reproductive Tract Infections Research, Genital Health and Disease, Hepatitis B Virus Studies, Blood Groups and Transfusion, Colorectal and Anal Carcinomas, and Microbial Infections and Disease Research.

Frequent publication venues for their work include:

  • SSRN Electronic Journal
  • Clinical Infectious Diseases
  • Vaccine
  • Journal of Medical Microbiology
  • The Journal of Infectious Diseases

They have collaborated often with the following co-authors:

  • Gerald L. Murray
  • Dorothy A. Machalek
  • Christopher K. Fairley
  • Catriona S. Bradshaw
  • Jennifer Danielewski

Recent publications of Suzanne M. Garland include:

  • "Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis," 2020, The Lancet Infectious Diseases
  • "The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men," 2020, Clinical Infectious Diseases
  • "Human Papillomavirus Vaccination After COVID-19," 2021, JNCI Cancer Spectrum
  • "Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study," 2021, The Lancet Infectious Diseases
  • "Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review," 2022, Expert Review of Vaccines

The scope of their work indicates a comprehensive engagement with infectious diseases, vaccine research, and cancer epidemiology, especially relating to human papillomavirus and associated conditions.

Best Publications

  • Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets

  • Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

    Suzanne M. Garland;Suzanne M. Garland;Mauricio Hernandez-Avila;Cosette M. Wheeler;Gonzalo Perez

  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

    J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler

  • A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

    Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard

  • Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

    Dorothy A Machalek;Mary Poynten;Fengyi Jin;Christopher K Fairley

  • High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence

    Catriona S. Bradshaw;Anna N. Morton;Jane Hocking;Suzanne M. Garland

  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis

    Mélanie Drolet;Élodie Bénard;Norma Pérez;Marc Brisson;Marc Brisson

  • Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn

  • A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

    John T. Schiller;Xavier Castellsagué;Suzanne M. Garland

  • Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

    Elmar A Joura;Sepp Leodolter;Mauricio Hernandez-Avila;Cosette M Wheeler

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Cosette M. Wheeler;Xavier Castellsagué;Suzanne M. Garland;Anne Szarewski

  • Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

    Suzanne M. Garland;Marc Steben;Heather L. Sings;Margaret James

  • Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

    Suzanne M. Garland;Susanne K. Kjaer;Nubia Muñoz;Stan L. Block

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

    Darron R. Brown;Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen

  • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    Nubia Munoz;Susanne K. Kjaer;Kristján Sigurdsson;Ole Erik Iversen

  • Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

    Warner K. Huh;Elmar A. Joura;Anna R. Giuliano;Ole Erik Iversen;Ole Erik Iversen

  • Web-Based Recruiting for Health Research Using a Social Networking Site: An Exploratory Study

    Yeshe Fenner;Suzanne M Garland;Elya E Moore;Yasmin Jayasinghe

  • Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data

    Elmar A. Joura;Suzanne M. Garland;Suzanne M. Garland;Jorma Paavonen;Daron Gale Ferris

  • A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen;Mauricio Hernandez-Avila

  • Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

    Joakim Dillner;Joakim Dillner;Susanne K. Kjaer;Cosette M. Wheeler;Kristján Sigurdsson

Frequent Co-Authors

Sepehr N. Tabrizi
Sepehr N. Tabrizi Royal Women's Hospital
Christopher K. Fairley
Christopher K. Fairley Monash University
Catriona S. Bradshaw
Catriona S. Bradshaw Monash University
John D. Wark
John D. Wark University of Melbourne
Andrew E. Grulich
Andrew E. Grulich University of New South Wales
Julia M.L. Brotherton
Julia M.L. Brotherton University of Melbourne
Jorma Paavonen
Jorma Paavonen University of Helsinki
Eric P F Chow
Eric P F Chow Monash University
Cosette M. Wheeler
Cosette M. Wheeler University of New Mexico
John M. Kaldor
John M. Kaldor University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various healthcare and science-related career paths. For those interested in the administrative side of healthcare, pursuing a certified professional coder certification can be a valuable step. This certification prepares graduates to work efficiently with medical coding and billing, a crucial component of healthcare data management.

Another promising field linked to microbiology is health information management, which combines healthcare knowledge with data organization and technology. Entry-level professionals can explore roles with competitive salaries, as outlined in the health information management salary entry-level resources.

For students seeking formal education online, programs accredited by the Commission on Accreditation for Health Informatics and Information Management Education are essential. Finding the cahiim accredited health information management degree online ensures quality training and better career prospects.

Additionally, accelerated options such as an accelerated medical billing and coding certificate online can help professionals enter the workforce quickly while gaining relevant skills that complement microbiology knowledge in clinical settings.

Best Scientists Citing Suzanne M. Garland

Trending Scientists

Recently Published Articles